Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer

Neoadjuvant chemotherapy (NACT) is used in locally advanced breast cancer to reduce tumour burden prior to surgical resection. However, only a subset of NACT treated patients will respond to treatment or achieve a pathologic complete response (pCR). This multicenter, prospective study (CTRIAL-IE (IC...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuire, Andrew, Casey, Maire-Caitlin, Waldron, Ronan M., Heneghan, Helen, Kalinina, Olga, Holian, Emma, McDermott, Ailbhe, Lowery, Aoife J., Newell, John, Dwyer, Róisín M., Miller, Nicola, Keane, Maccon, Brown, James A.L., Kerin, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408914/
https://www.ncbi.nlm.nih.gov/pubmed/32645898
http://dx.doi.org/10.3390/cancers12071820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408914/
https://www.ncbi.nlm.nih.gov/pubmed/32645898
http://dx.doi.org/10.3390/cancers12071820

Ejemplares similares